Literature DB >> 30896296

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects.

Yu Shi1, Yuqi Yang2, Qinyu Guo1, Qiuzhi Gao1, Ying Ding1, Hua Wang3, Wenrong Xu1, Bin Yu2, Mei Wang1, Yuanyuan Zhao1, Wei Zhu1.   

Abstract

Cardioprotective effects of exosomes derived from human umbilical cord mesenchymal stem cells (hucMSC-exosomes) postmyocardial infarction (post-MI) have been reported in our previous study. It is known that fibroblasts are pro-inflammatory phenotypes, while myofibroblasts are anti-inflammatory phenotypes. This study aimed to investigate whether hucMSC-exosomes promoted cardiac fibroblast-to-myofibroblast differentiation in inflammatory environments and protected cardiomyocytes. Rats were performed by permanent ligation of the left anterior descending coronary artery and underwent intramyocardial injection of hucMSC-exosomes or phosphate-buffered saline (PBS) in surgery. Fibroblasts were stimulated by lipopolysaccharide (LPS) to create inflammatory environments in vitro. Western blot and immunohistochemical and immunofluorescence staining for α-smooth muscle actin were used to demonstrate fibroblast-to-myofibroblast differentiation. Transwell migration assay and CCK-8 assay were used to evaluate migration and proliferation of fibroblasts. Reverse transcription-polymerase chain reaction, western blot, and immunohistochemical staining were used to detect expressions of inflammatory factors. To investigate cardioprotective effects, cardiomyocytes were treated with supernatant derived from fibroblasts pretreated with LPS or LPS plus hucMSC-exosomes in hypoxic environments. Cardiomyocyte apoptosis was determined using TUNEL assay and western blot. Results indicated that hucMSC-exosomes increased the density of myofibroblasts in infarct areas during inflammatory phases post-MI, promoted fibroblast-to-myofibroblast differentiation in inflammatory environments, and attenuated inflammatory responses in vitro and in vivo. Culture medium derived from fibroblasts pretreated with LPS plus hucMSC-exosomes reduced cardiomyocyte apoptosis. In vivo, apoptotic cells in acute myocardial infarction (AMI)+exosomes groups were also less than AMI+PBS groups. In conclusion, hucMSC-exosomes can promote fibroblast-to-myofibroblast differentiation in inflammatory environments, then protecting cardiomyocytes.

Entities:  

Keywords:  cardioprotection; exosomes; fibroblast; mesenchymal stem cells; myofibroblast differentiation

Mesh:

Substances:

Year:  2019        PMID: 30896296     DOI: 10.1089/scd.2018.0242

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  14 in total

1.  Extracellular vesicles derived from human bone marrow mesenchymal stem cells protect rats against acute myocardial infarction-induced heart failure.

Authors:  Liying Xuan; Danni Fu; Dong Zhen; Chengxi Wei; Dongsong Bai; Lijun Yu; Guohua Gong
Journal:  Cell Tissue Res       Date:  2022-05-07       Impact factor: 5.249

2.  Role of Exosomes in Dermal Wound Healing: A Systematic Review.

Authors:  Anesh Prasai; Jayson W Jay; Daniel Jupiter; Steven E Wolf; Amina El Ayadi
Journal:  J Invest Dermatol       Date:  2021-08-27       Impact factor: 7.590

Review 3.  Mesenchymal Stromal Cell Exosomes in Cardiac Repair.

Authors:  Darukeshwara Joladarashi; Raj Kishore
Journal:  Curr Cardiol Rep       Date:  2022-01-29       Impact factor: 3.955

Review 4.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

5.  Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Prevent Acidic pH-Induced Damage in Human Nucleus Pulposus Cells.

Authors:  Ming Li; Ruoyu Li; Sidong Yang; Dalong Yang; Xianda Gao; Jiayuan Sun; Wenyuan Ding; Lei Ma
Journal:  Med Sci Monit       Date:  2020-05-21

Review 6.  Perspectives for Future Use of Extracellular Vesicles from Umbilical Cord- and Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells in Regenerative Therapies-Synthetic Review.

Authors:  Joanna Lelek; Ewa K Zuba-Surma
Journal:  Int J Mol Sci       Date:  2020-01-25       Impact factor: 5.923

Review 7.  The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction.

Authors:  Yu-Yan Xiong; Zhao-Ting Gong; Rui-Jie Tang; Yue-Jin Yang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 8.  Extracellular Vesicle-Based Therapeutics for Heart Repair.

Authors:  Laura Saludas; Cláudia C Oliveira; Carmen Roncal; Adrián Ruiz-Villalba; Felipe Prósper; Elisa Garbayo; María J Blanco-Prieto
Journal:  Nanomaterials (Basel)       Date:  2021-02-25       Impact factor: 5.076

Review 9.  Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions.

Authors:  Sean T Ryan; Elham Hosseini-Beheshti; Dinara Afrose; Xianting Ding; Binbin Xia; Georges E Grau; Christopher B Little; Lana McClements; Jiao Jiao Li
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

10.  Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis.

Authors:  Xue Wang; Yuhai Zhu; Chengcheng Wu; Wennan Liu; Yujie He; Qing Yang
Journal:  Inflammation       Date:  2021-04-21       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.